2002
DOI: 10.1099/00221287-148-6-1747
|View full text |Cite
|
Sign up to set email alerts
|

Organization and characterization of the capsule biosynthesis locus of Streptococcus pneumoniae serotype 9V The GenBank accession number for the sequence reported in this paper is AF402095.

Abstract: The capsular polysaccharide (CPS) synthesis locus of Streptococcus pneumoniae serotype 9V was amplified by long-range PCR and sequenced. The locus was 17 368 bp in size and contained 15 ORFs. The genetic organization of the cluster shared many features with other S. pneumoniae capsule loci, including the presence of four putative regulatory genes at the 5' end. Comparative sequence analyses allowed putative functions to be assigned to each of the gene products. The ORFs appeared to encode, besides the four reg… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
26
0

Year Published

2003
2003
2015
2015

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 35 publications
(27 citation statements)
references
References 56 publications
1
26
0
Order By: Relevance
“…Indeed, this was true for serotype 9V, where sequetyping of our strains matched both serotypes 9A and 9V of the representative strains initially interrogated. However, additional 9V strain sequences deposited in GenBank during our study matched precisely our 9V sequence, resulting in correct identification (63). Conversely, some serotypes could not be sequetyped, contrary to the in silico predictions.…”
Section: Discussionmentioning
confidence: 48%
“…Indeed, this was true for serotype 9V, where sequetyping of our strains matched both serotypes 9A and 9V of the representative strains initially interrogated. However, additional 9V strain sequences deposited in GenBank during our study matched precisely our 9V sequence, resulting in correct identification (63). Conversely, some serotypes could not be sequetyped, contrary to the in silico predictions.…”
Section: Discussionmentioning
confidence: 48%
“…Moreover, there is the possibility of expanding the method to cover the detection of more capsular types. Based on the recent publication of the complete sequence of a 9V capsular locus (29) and the public release of partial sequences of capsular loci 6A and 6B by Griffiths and Hall (GenBank accession no. AF246898, AY078347, AY078342, AY078343, AY078344, AY078341, AY078339, AY078345, AY078340, and AY078346), we designed new primers to allow the identification of these serotypes and the expansion of our typing scheme.…”
Section: Discussionmentioning
confidence: 99%
“…The three additional capsular determinants for serotypes 5, 7F, and 9V also present in this vaccine had not been sequenced at the time this method was developed; the sequence for serotype 9V was recently published (29). Based on Southern hybridization results (14,19,22) and sequence homologies, the primers in this second class were designed to target different genes which were as follows: gene wzy for serotypes 1 (21), 4 (11), 6B (11), 14 (13), and 19F (6) (initially named cpsH and cpsI for serotypes 14 and 19F, respectively); gene capB for serotype 3 (2); genes wciY and gct for serotype 18C (11); gene cpsK for serotype 19A (19); and gene cpsG for serotype 23F (22).…”
Section: Molecular Capsular Typing (I) Oligonucleotide Primersmentioning
confidence: 99%
“…Eleven serotype 14 strains and 39 serotype 9V strains from a previous study were included (17). In addition, the cpsB genes from 15 international pneumococcal clones (18) and 23 strains listed in GenBank (3,9,[11][12][13][14][15]19,20,22,23,25,29) were analyzed ( Table 1).…”
Section: Methodsmentioning
confidence: 99%